No Data
Earnings Preview: CRVS to Report Financial Results Post-market on November 12
$Corvus Pharmaceuticals(CRVS.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $Corvus Pharmaceuticals(CRVS.US)$ to post revenue of
Express News | Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024
Daily options tracking | Up 14% after hours! Palantir pre-earnings options trading volume increased by 1.2 times; US bond etf call options made a profit of 200%, implied volatility level approaching historical highs before the election.
Nvidia rose by 0.48% yesterday, with its market cap surpassing Apple to become the global number one at one point. A big player bought calls worth 3 million USD; there are 45 million USD in put options on SPY, with big players betting on a drop in the S&P 500 by the end of the year.
Corvus Stock Climbs 7% Following Mizuho Upgrade
Mizuho Securities Upgrades Corvus Pharmaceuticals(CRVS.US) to Buy Rating, Announces Target Price $12
Express News | Corvus Pharmaceuticals Inc : Mizuho Raises to Outperform From Neutral